Skip to Main Content

Author Details

Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
2006
47
28
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36564564Use the term "infiltrative" instead of "replacement" when defining histopathological growth pattern in patients with liver cancer.Br J Cancer2023
36564564Use the term "infiltrative" instead of "replacement" when defining histopathological growth pattern in patients with liver cancer.Br J Cancer2023
35847575MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere's disease and vascular congestion over the endolymphatic sac.J Otol2022
35847575MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere's disease and vascular congestion over the endolymphatic sac.J Otol2022
32194289Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.Biol Blood Marrow Transplant2020
32194289Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.Biol Blood Marrow Transplant2020
30510241Discovery of common and rare genetic risk variants for colorectal cancer.Nat Genet2019
30510241Discovery of common and rare genetic risk variants for colorectal cancer.Nat Genet2019
30867038Correction to: NSAID use and somatic exomic mutations in Barrett's esophagus.Genome Med2019
31406955Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.JCO Precis Oncol2019
31406955Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.JCO Precis Oncol2019
30867038Correction to: NSAID use and somatic exomic mutations in Barrett's esophagus.Genome Med2019
29348127Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Blood2018
30046007The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.JCI Insight2018
29486792NSAID use and somatic exomic mutations in Barrett's esophagus.Genome Med2018
29348127Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.Blood2018
29425228KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.PLoS One2018
30046007The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.JCI Insight2018
29425228KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.PLoS One2018
29486792NSAID use and somatic exomic mutations in Barrett's esophagus.Genome Med2018
28007623Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).J Thorac Oncol2017
28007623Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).J Thorac Oncol2017
26887344Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.Am J Transplant2016
27195312Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.JCI Insight2016
26887344Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.Am J Transplant2016
27217465Biomarker Panel for Chronic Graft-Versus-Host Disease.J Clin Oncol2016
27195312Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.JCI Insight2016
27217465Biomarker Panel for Chronic Graft-Versus-Host Disease.J Clin Oncol2016
25744723Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.Cancer Res2015
25744723Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival.Cancer Res2015
26172478Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant2015
26673326Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.Cell Rep2015
26673326Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells.Cell Rep2015
26172478Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant2015
23791624A novel soluble form of Tim-3 associated with severe graft-versus-host disease.Biol Blood Marrow Transplant2013
23924003ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.N Engl J Med2013
23791624A novel soluble form of Tim-3 associated with severe graft-versus-host disease.Biol Blood Marrow Transplant2013
23924003ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.N Engl J Med2013
22407608Integration of proteomics into systems biology of cancer.Wiley Interdiscip Rev Syst Biol Med2012
22277732Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.Cancer Prev Res (Phila)2012
22411897Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.Mol Cancer Ther2012
22367215Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.Cancer Res2012
22407608Integration of proteomics into systems biology of cancer.Wiley Interdiscip Rev Syst Biol Med2012
22277732Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.Cancer Prev Res (Phila)2012
22367215Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.Cancer Res2012
22411897Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition.Mol Cancer Ther2012
21062094Mining the plasma proteome for disease applications across seven logs of protein abundance.J Proteome Res2011
21062094Mining the plasma proteome for disease applications across seven logs of protein abundance.J Proteome Res2011
21829587Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma.PLoS One2011
21653680Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.Cancer Res2011
  • 1 - 50 of 94

Recommended Authors

Margaret Cancer Center
Career Start Year 2016
Number of shared co-authors 2
Max Planck Institute of Biochemistry
Career Start Year 2011
Number of shared co-authors 0
Macquarie Medical School, Macquarie University
Career Start Year 2011
Number of shared co-authors 3
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Uppsala University
Career Start Year 2008
Number of shared co-authors 3
Yale University School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 0
Queen's University of Belfast
Career Start Year 2007
Number of shared co-authors 3
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 1
Yonsei University
Career Start Year 2005
Number of shared co-authors 7
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2005
Number of shared co-authors 0
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 0
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 1
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 4
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 0
Tel Aviv University
Career Start Year 2000
Number of shared co-authors 1
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 5
Hospital for Sick Children
Career Start Year 1999
Number of shared co-authors 1
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 3
Pacific Northwest National Laboratory
Career Start Year 1998
Number of shared co-authors 4
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 0
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Career Start Year 1996
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 3
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 8
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 1984
Number of shared co-authors 7
Broad Institute of MIT and Harvard
Career Start Year 1980
Number of shared co-authors 9

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 34
Stanford University
Co-authored papers 17
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 12
University of Michigan ann arbor
Co-authored papers 5
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 4
Co-authored papers 3
Massachusetts General Hospital
Co-authored papers 3
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 3
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
University of Michigan Medical School ann arbor
Co-authored papers 2
OncProTech LLC
Co-authored papers 2
and School of Public Health, University of Michigan ann arbor
Co-authored papers 2
Boston Children's Hospital
Co-authored papers 2
University of Washington
Co-authored papers 2
Stanford University
Co-authored papers 2
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 2
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Northwestern University
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Stanford University.
Co-authored papers 1
Co-authored papers 1
Temple University College of Public Health
Co-authored papers 1
Lerner Research Institute, Cleveland Clinic
Co-authored papers 1
Co-authored papers 1